Janet L. Markman

2.3k citations

21 papers · 1.5k indexed · 1 hit paper · h-index 15

Co-authors: Julia Y. Ljubimova Arthur Rekechenetskiy Stephen L. Shiao Moshe Arditi Shuang Chen Keith L. Black Bindu Konda Eggehard Holler
Topics: Immunotherapy and Immune Responses (7 papers)Inflammasome and immune disorders (4 papers)RNA Interference and Gene Delivery (3 papers)
Cited by: Biomaterials Immunology Oncology
Journals: Nature Nature CommunicationsSHILAP Revista de lepidopterología
Partner nations: United States Germany Spain

In The Last Decade

Janet L. Markman

20 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nanomedicine therapeutic approaches to overcome cancer drug resistance

2013 600 citations Janet L. Markman, Arthur Rekechenetskiy et al. Advanced Drug Delivery Reviews profile →

Peers

Countries citing papers authored by Janet L. Markman

Since Specialization

Citations

This map shows the geographic impact of Janet L. Markman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janet L. Markman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janet L. Markman more than expected).

Fields of papers citing papers by Janet L. Markman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janet L. Markman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janet L. Markman. The network helps show where Janet L. Markman may publish in the future.

Co-authorship network of co-authors of Janet L. Markman

This figure shows the co-authorship network connecting the top 25 collaborators of Janet L. Markman. A scholar is included among the top collaborators of Janet L. Markman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janet L. Markman. Janet L. Markman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	1605MO Primary results from a randomized phase II trial of BNT111 in combination with cemiplimab with calibrator monotherapy arms in anti-PD-(L)1 relapsed/refractory melanoma 2025 ·Annals of Oncology ·(unknown),Stephan Grabbe,Michele Guida,(unknown),(unknown),(unknown),Janet L. Markman,(unknown),Hushan Yang,Katarina Ćuk,(unknown),(unknown),(unknown),Michael J. Wenger,(unknown),Frank Seebach,(unknown),(unknown),Uğur Şahin,(unknown)	0
2	Abstract CT051: Preliminary results from LuCa-MERIT-1, a first-in-human Phase I trial evaluating the fixed antigen mRNA vaccine BNT116 + docetaxel in patients with advanced non-small cell lung cancer 2024 ·Cancer Research ·(unknown),David Vicente Baz,Jürgen Wolf,Öztürk Ateş,Erdem Göker,Patrick T. Bruck,Michael J. Wenger,Neru Munshi,(unknown),(unknown),Małgorzata A. Kaczorowska,(unknown),Janet L. Markman,Huyuan Yang,Özlem Türeci,Uğur Şahin,Patrick M. Forde,Akin Atmaca	6
3	Lymphodepletion – an essential but undervalued part of the chimeric antigen receptor T-cell therapy cycle 2023 ·Frontiers in Immunology ·(unknown),Lulu Chu,(unknown),(unknown),Pere Barba,Matteo Doglio,David Henderson,Michael Hudecek,Andreas Kremer,Janet L. Markman,Magdalena Nauerth,Hélène Negre,Carmen Sanges,Philipp B. Staber,(unknown),Julio Delgado,Dirk H. Busch,Jürgen Kuball,Maik Luu,Ulrich Jäger	75
4	597 Preliminary results from LuCa-MERIT-1, a first-in-human Phase I trial evaluating the fixed antigen RNA vaccine BNT116 in patients with advanced non-small cell lung cancer 2023 ·SHILAP Revista de lepidopterología ·(unknown),(unknown),Erdem Göker,István Láng,Patrick T. Bruck,Michael J. Wenger,Neru Munshi,(unknown),(unknown),Janet L. Markman,Petra Rietschel,Huyuan Yang,Oezlem Tuereci,Uğur Şahin,Akin Atmaca,Patrick M. Forde	7
5	737 Interim results of a first-in-human phase 1 dose-escalation trial of TAK-102, a glypican-3 targeted armored chimeric antigen receptor T-cell immunotherapy in patients with advanced solid tumors 2022 ·Regular and Young Investigator Award Abstracts ·Takafumi Koyama,Toshio Shimizu,Toshihiko Doi,Noboru Yamamoto,Shunsuke Kondo,(unknown),(unknown),Janet L. Markman,Takenori Akaike,(unknown),Yasutoshi Kuboki	1
6	Sex-Specific Effects of the Nlrp3 Inflammasome on Atherogenesis in LDL Receptor-Deficient Mice 2020 ·JACC Basic to Translational Science ·Shuang Chen,Janet L. Markman,Kenichi Shimada,Timothy R. Crother,(unknown),(unknown),Prediman K. Shah,Moshe Arditi	46
7	C9orf72 in myeloid cells suppresses STING-induced inflammation 2020 ·Nature ·(unknown),Jacqueline G. O’Rourke,Alberto Yáñez,Janet L. Markman,Ritchie Ho,Xinchen Wang,Shuang Chen,Deepti Lall,Mengyao Jin,A.K.M. Ghulam Muhammad,Shaughn Bell,(unknown),(unknown),Matthew Harms,Moshe Arditi,Caroline A. Jefferies,Robert H. Baloh	203
8	Oxidative DNA Damage Accelerates Skin Inflammation in Pristane-Induced Lupus Model 2020 ·Frontiers in Immunology ·Gantsetseg Tumurkhuu,Shuang Chen,Erica N. Montano,(unknown),(unknown),Jeong Min Yu,(unknown),M Yamashita,Janet L. Markman,Luz P. Blanco,Mariana J. Kaplan,Kenichi Shimada,Timothy R. Crother,Mariko Ishimori,Daniel J. Wallace,Caroline A. Jefferies,Moshe Arditi	39
9	Loss of testosterone impairs anti-tumor neutrophil function 2020 ·Nature Communications ·Janet L. Markman,Rebecca A. Porritt,Daiko Wakita,(unknown),Daisy Martinon,Magali Noval Rivas,Michael Luu,Edwin M. Posadas,Timothy R. Crother,Moshe Arditi	44
10	Interleukin-1 Beta–Mediated Sex Differences in Kawasaki Disease Vasculitis Development and Response to Treatment 2020 ·Arteriosclerosis Thrombosis and Vascular Biology ·Rebecca A. Porritt,Janet L. Markman,Daisuke Maruyama,Begüm Kocatürk,Shuang Chen,Thomas J A Lehman,Youngho Lee,Michael C. Fishbein,Magali Noval Rivas,Moshe Arditi	43
11	T-Cell-Intrinsic Receptor Interacting Protein 2 Regulates Pathogenic T Helper 17 Cell Differentiation 2018 ·Immunity ·Kenichi Shimada,Rebecca A. Porritt,Janet L. Markman,Jacqueline G. O’Rourke,Daiko Wakita,Magali Noval Rivas,Chihiro Ogawa,Lina Kozhaya,Gislâine A. Martins,Derya Unutmaz,Robert H. Baloh,Timothy R. Crother,Shuang Chen,Moshe Arditi	20
12	Impact of the immune system and immunotherapy in colorectal cancer. 2015 ·PubMed ·Janet L. Markman,Stephen L. Shiao	156
13	MRI Virtual Biopsy and Treatment of Brain Metastatic Tumors with Targeted Nanobioconjugates: Nanoclinic in the Brain 2015 ·ACS Nano ·Rameshwar Patil,Alexander V. Ljubimov,Pallavi R. Gangalum,Hui Ding,José Portilla‐Arias,Shawn Wagner,Satoshi Inoue,Bindu Konda,Arthur Rekechenetskiy,Alexandra Chesnokova,Janet L. Markman,Vladimir A. Ljubimov,Debiao Li,Ravi S. Prasad,Keith L. Black,Eggehard Holler,Julia Y. Ljubimova	73
14	Gene expression changes in rat brain after short and long exposures to particulate matter in Los Angeles basin air: Comparison with human brain tumors 2013 ·Experimental and Toxicologic Pathology ·Julia Y. Ljubimova,Michael T. Kleinman,(unknown),Satoshi Inoue,Bindu Konda,Pallavi R. Gangalum,Janet L. Markman,Alexander V. Ljubimov,Keith L. Black	22
15	Nanomedicine therapeutic approaches to overcome cancer drug resistancebreakdown → 2013 ·Advanced Drug Delivery Reviews ·Janet L. Markman,Arthur Rekechenetskiy,(unknown),Julia Y. Ljubimova	600
16	Toxicity and efficacy evaluation of multiple targeted polymalic acid conjugates for triple-negative breast cancer treatment 2013 ·Journal of drug targeting ·Julia Y. Ljubimova,José Portilla‐Arias,Rameshwar Patil,Hui Ding,Satoshi Inoue,Janet L. Markman,Arthur Rekechenetskiy,Bindu Konda,Pallavi R. Gangalum,Alexandra Chesnokova,Alexander V. Ljubimov,Keith L. Black,Eggehard Holler	44
17	Abstract A50: Nanobiocojugates of differential imaging and treatment of brain metastatic tumors 2013 ·Cancer Research ·Julia Y. Ljubimova,Rameshwar Patil,Pallavi R. Gangalum,Shawn Wagner,Satoshi Inoue,Hui Ding,(unknown),(unknown),(unknown),Janet L. Markman,Alexandra Chesnokova,Keith L. Black,Eggehard Holler	1
18	Polymalic acid nanobioconjugate for simultaneous immunostimulation and inhibition of tumor growth in HER2/neu-positive breast cancer 2013 ·Journal of Controlled Release ·Hui Ding,Gustavo Helguera,José A. Rodríguez,Janet L. Markman,Rosendo Lurı́a-Pérez,Pallavi R. Gangalum,José Portilla‐Arias,Satoshi Inoue,Tracy R. Daniels‐Wells,Keith L. Black,Eggehard Holler,Manuel L. Penichet,Julia Y. Ljubimova	37
19	Nanobiopolymer for Direct Targeting and Inhibition of EGFR Expression in Triple Negative Breast Cancer 2012 ·PLoS ONE ·Satoshi Inoue,Rameshwar Patil,José Portilla‐Arias,Hui Ding,Bindu Konda,(unknown),Dmitriy Mongayt,Janet L. Markman,(unknown),H. Westley Phillips,Keith L. Black,Eggehard Holler,Julia Y. Ljubimova	45
20	Treg cells in pancreatic lymph nodes: the possible role in diabetogenesis and β cell regeneration in a T1D model 2012 ·Cellular and Molecular Immunology ·(unknown),Janet L. Markman,Suzanne Bertera,Alexis Styche,(unknown),Владимир Субботин,Massimo Trucco,(unknown)	28

About Janet L. Markman

Janet L. Markman is a scholar working on Immunology, Oncology and Biomaterials, having authored 21 papers that have together received 1.5k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (7 papers), Inflammasome and immune disorders (4 papers) and RNA Interference and Gene Delivery (3 papers). The work is most often cited by research in Biomaterials (429 citations), Immunology (351 citations) and Oncology (382 citations). Janet L. Markman has collaborated with scholars based in United States, Germany and Spain. Frequent co-authors include Julia Y. Ljubimova, Arthur Rekechenetskiy, Stephen L. Shiao, Moshe Arditi, Shuang Chen, Keith L. Black, Bindu Konda, Eggehard Holler, Caroline A. Jefferies and Hui Ding. Their work appears in journals such as Nature, Nature Communications and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact